Outer membrane protein 16 from Brucella abortus expression in Arabidopsis thaliana Overview of my Msc thesis project Prof. Dr. Mirza Suljagić Student: Jasmin Šutković Sarajevo , 18th September 2014 Content • • • • • • Introduction Objectives Material and Methods Short discussion of the current work Expected outcomes References Introduction Brucellae are facultative intracellular gram-negative bacteria that causes : -human disease and significant worldwide economic loss due to infection of livestock by Brucelosis . - in wild animals it causes late gestation abortion in pregnant females The Brucella cell wall consists of a peptidoglycan layer strongly associated with the outer membrane. The molecular characterization of several of these outer membrane proteins (OMPs) has been reported over the past years. Outer membrane proteins (OMPs) • Several Brucella Outer membrane proteins (OMPs) have been characterized in the past several years. One of these proteins is the 16-kDa OMP, named Omp16. • Omp16 is a lipoprotein that it is exposed at the bacterial surface (Tibor et al.1999) and found in all biovars of B. abortus, B. melitensis, B. suis, B. canis, B. ovis, and B. neotomae (Pasquevich et al.,2009). • It is confirmed that Omp16 as a lipoprotein activates monocytes, inducing the production of proinflammatory cytokines (Ibañezet al., 2013). Introduction cont... • In humans, brucelosis causes fever, resembling to a flu-like illness. DEFENSE MECHANISM • Although both Ab- and cell-mediated immune responses can influence the course of infection with Brucella, also IFN-g (cytokine) plays a central role in acquired resistance against Brucella, by up-regulating macrophage microbial killing. • Because brucellosis has serious medical and economic consequences, prevention of animal infection by vaccination is key. Current prevention of brucellos • All commercially available brucellosis vaccines are based on live, attenuated strains of Brucella. • Although effective, these vaccines have disadvantages: o they can be infectious for humans; o they can interfere with diagnosis; o they may result in abortions when administered to pregnant animals; and o the vaccine strain can spread in the region Currently, no vaccine against human brucellosis is available Possible vaccines …. • Therefore, improved vaccines that combine safety and efficacy to all species at risk need to be designed. • Several trials have been made to develop a vaccine without these drawbacks, a vaccine that would be more effective and safer than those used at present ! • Subunit vaccines, like recombinant proteins, are promising vaccine candidates, because they can be produced at high yield and purity and can be manipulated to maximize desirable activities and minimize undesirable ones. However, despite these advantages, Subunit vaccines tend to be poorly immunogenic in vivo, and require the adjuvants that indirectly enhance the immune response against recombinant proteins Therefore, an oral vaccine could be a promising candidate to control the disease or to enhance the immune protection provided by currently available vaccines • It was reported that B. abortus Omp16 confers protection against a challenge with virulent B. abortus when administered intraperitoneal (i.p.)with systemic adjuvants (IFA or aluminum hydroxide) or orally with a mucosal adjuvant (cholera toxin) (Pasquevich, K. et al.,2009) Karina A. et al. in 2010, showed that a potential subunit vaccine U-OMP16 elicit a protective immune response without the need of external adjuvant. U-OMP16, expressed in Nicotiana benthamiana, induced a protective immune response against a challenge with virulent B. abortus when given to mice without external adjuvants, indicating that Omp16 lipoprotein has an intrinsic adjuvanticity. Objectives • The initial objective of this study was the transformation of Arabidopsis thaliana via Agrobacterium tumefaciens , to express and then to verify the expression of U-OMP 16 in this plant. • Due to the time limitation to finish the project completely within this academic year, transformation of A.thaliana can not be done within this timeframe , but it will be completed within the following 2-3 months. • This thesis was supported and granted with the essential chemicals by IUS, as being the first project of this kind in our labs. Materials • Brucella genomic DNA (received from University of Ankara in Turkey, Department of General Biology, Dr. Adiguzel) • Arabidopsis thaliana seeds, ecotype Col-O (from Agricultural Biotechnology Centre, Szent-Gyorgyi, Hungary , Dr.Nyiko Tunde) • Agrobacterium tumefaciens, strain GV3101 (from Agricultural Biotechnology Centre, Szent-Gyorgyi, Hungary , Dr.Nyiko Tunde) • Ecoli DH5α cells (provided by prof. Mirza Suljagic) • pBI101.1 plasmid (from : Arabidopsis thaliana research center) Methods and Results Cultivation and maintenance of Arabidopsis thaliana seeds stock • Arabidopsis thaliana, ecotype Columbia (Col) was used as wild type • Seeds are sterilizes with 70% ethanol for 5 min following an in 10 % (v/v) bleach containing 0.1% (v/v) Triton X for 15 minutes. • One month prior transformation, approximately 10 pots (12x6x4 cm) shall be prepared and for each pot up to 15 seeds. • The pots are placed for three days in a cold room or +4 fridge to to break the dormancy phase • Than, I placed the pots into the Growth Chamber (16h night, 8h light, 22C 120mmol/m2x sec)- and leave it for one month to grow . • When the plants have just bolted and began to flower they are ready for transformation , so to increase the transformation efficiency, 3-4 days before transformation we trim off the main inflorescence shoots as soon as they have grown to ensure the secondary shoot formation . Arabidopsis thaliana grown in IUS laboratory growth chamber Brucella abortus genomic DNA • Due to the lack of Biosafety II level in the Genetics and Bioengineering labs at IUS, the genomic DNA from Brucella abortus was isolated and obtained from the University of Ankara in Turkey, Department of General Biology. • The B.abortus genomic DNA was isolated from positive tested Eastern Red cow milk samples, located in the Eastern Anatolia Region of Turkey. These cows had a history of abortion (Arasoglu et al., 2013). Working with Agrobacterium tumefaciens , strain GV3101 The A.tumefaciens (GV3101) bacterial cells were received in LB agar plate ( with the appropriate antibiotics for selection – see table 1). Bacterial cells were picked from the solid LB medium by scratching the sterile loop across the surface of the cultures. New cells were grown in LB medium at 30C overnight and stored as glycerol stock for long storage ,for short storage I prepared LB plates. In addition competent cells were made using CaCl2 method. Working with DH5 α E.coli cells • Empty DH5α cells were grown in LB medium at 37C overnight. • DH5 α cells harboring the pBI101.1 plasmid were treated very same as the empty DH5 α cells just with appropriate antibiotics (Kanamycine) o The vector pBI101.1, was received as a bacterial stab in a 2 ml micro centrifuge tube in LB agar. o According the study from 1987 (Richards Jefferson) the pBI101.1 plasmid initially was thought to be of 12.2 kb a o In the later study, conducted by P.Y Chen et al. in 2003 on the pBI121 vector he proved that that the plasmid pBI121 has the size of 14.758bp o Plasmid pBI101.1 is the same as pBI121 but only without the CaMV 35S promoter. o Using a trial version of SnapGene software I have designed the pBI101 plasmid. Figure 2: Circular map of vector pBI101.1 designed with SnapGene tool. - pBI101.1 plasmid extraction from DH5 α cells was done with the QIAGEN Plasmid plus Midi kit , the final volume was 250 µl. The isolated plasmid was run on 0.8 % agarose gel and compared to 1kb marker for its size. Dilutions were prepared, 0.1µl, 0.5µl, 1µl and 2µl respectively. The expected bands of 13.290bp each is clearly seen of figure shown below. - Agarose gel electrophoresis of pBI101.1 product - In addition, DNA – plasmid quantification with UV/VIS spectrophotometer was done to check the plasmid concentration The measurement was done with Lambda 25 Perkin Elmer UV/VIS spectrophotometer , diluting our sample 100 X with dH2O. 10µl of isolated plasmid was added to 990 µl dH2O. Formula used to calculate the 260:280 concentrations is the following: Unknown mg/ml = 50 mg/ml x Measured A260 x dilution factor The OD reading showed 0.1 A. The dilution factor is 100 .The following concentration was measured: pB101.1 mg/ml = 50 mg/ml x 0.1 x 100 = 500 µg/ml or 500 ng/µl, resulting in a final concentration of 0.5 µg / µl. PCR amplification of insert Table 2: PCR mix COMPONENTS No. of CYCLES VOLUME PCR STEPS TEMPERATURE DURATION Taq polymerase buffer(10X) 5 μl Initial Denaturation 95°C 2 minutes MgCl2 (25 mM) 5 μl Denaturation 94°C 30 seconds dNTPs (10mM) 1 μl Annealing 60°C 1 minute Primer forward (10μΜ) 1 μl Primer elongation 72°C 1 minute Primer reverse (10μΜ) 1 μl Final elongation 72 °C 5 minutes 1x DNA template (0.5 ng/μl) 1 μl Hold 4°C Forever ∞ Taq Polymerase (5 U/μl) 0.5 μl ddH2O 35.5 μl Total volume 50 μl 38 cycles Table 3: Oliginucletide primers used for this study Primer names uOMP16 (insert) Primer Sequence (5 ---˃ 3) F: CGAAGCTTATGTGCGTCAAAGAAGAACCTTCCG R: CTTCTAGATTAGTGATGGTGATGATGATGCCGTCCGGCCCCGTTGTT R2: CTTCTAGATTACCGTCCGGCCCCGTTGAGAACGGT Omp25 (control) F: ATGCGCACTCTTAAGTCTC R: GCCGAGGATGTTGTCCGT Note : The uOMP16 R1 primer included also the histidine 6x tag Omp25 protein is encoded by a nucleotide sequence of 490bp (Arasoğlu et al., 2013) PCR amplification results of OMP25 and uOMP16 1kb -- omp25 uOMP16 490bp 432bp 1% agarose gel Restriction digest of pBI101.1 vector and insert • During the vector restriction digest we are incubating our plasmid and insert with a pair of restriction enzymes, Hind III and XbaI that cut our DNA material produce DNA molecules with sticky ends. • Double digestion is used with SB buffer, where the activity of HindIII is 100% and 75%-100% of XbaI, respectively. Restriction mix: 11µl dH2O 5 µl SB buffer 30 µl of plasmid (pBI101) or insert 2 µl Hind III 2 µl XbaI Total reaction volume: 50 µl Left for incubation for minimum 2h at 37C Ligation • During the ligation step we have mixed the linearized vector and the inert together by adding T4 ligase which fuses their ends to form a circular plasmid. • For the negative control we did not add the insert to the ligation mix. • For the vector-insert ratio we have compared the digested vector and plasmid on 1% agarose gel by length and the general thickness of bands. In addition, the ratio of insert to vector was also determined according the concentration of vector and insert determined by spectrophotometer quantification of digested plasmid and insert. • The insert – vector mass ratio was calculated according the following formula: 𝒏𝒈 𝒐𝒇 𝒗𝒆𝒄𝒕𝒐𝒓 𝑿 𝒌𝒃 𝒐𝒇 𝒊𝒏𝒔𝒆𝒓𝒕 𝒊𝒏𝒔𝒆𝒓𝒕 𝑿 𝒎𝒐𝒍𝒂𝒓 𝒓𝒂𝒕𝒊𝒐 𝒌𝒃 𝒐𝒇 𝒗𝒆𝒄𝒕𝒐𝒓 𝒗𝒆𝒄𝒕𝒐𝒓 Table 3:Ligation mix Minus control 1:3 ratio 1:6 ratio Volume Volume Volume dH2O 16 µl 13 µl 10 µl T4 ligase buffer 2 µl 2 µl 2 µl Vector (900ng/µl) 1 µl 1 µl 1 µl Insert (800ng/µl) No 3 µl 6 µl T4 ligase 1 µl 1 µl 1 µl Total 20 µl 20 µl 20 µl Component Ecoli DH5 α transformation For the transformation new competent DH5α cells were prepared using ice cold CaCl2 method Transformation was done using Heat Shock method: For the transformation of E.coli DH5α cells the ligation product (20 μl) was mixed with a 100μl aliquot of competent cells and left for 30 minutes for incubation on ice. After the incubation time the mix is exposed to 42°C in water bath for 1 min and transferred on ice for 2 to 3 min. 400 μL of LB medium (no antibiotics) are added and bacteria are incubated for 1h in a 37°C water bath. Bacteria are then plated onto agar plate (with kanamycine) and incubated overnight at 37°C (Hanahan et al., 1983). Around 200 bacterial colonies 1:3 ligation plate Around 40 bacterial colonies 1:6 ligation plate • For verification of transformation plasmid DNA was isolated from several bacterial colonies. • Randomly picked 12 bacterial colonies from 1: 3 plate were previously grown overnight in 3 ml liquid LB medium with appropriate antibiotics at 37C. • Plasmid DNA was isolated with plasmid miniprep DNA extraction kit from Invitrogen. • The isolated plasmid DNA, named as pBI101:uOMP16, was firstly run on PCR to check for our insert with the primer we have used for our insert amplification from Brucella genomic DNA __ PCR amplification of the insert from our plasmid construct • In addition the isolated plasmid will be digested with HIND III and XbaI in total reaction volume of 30µl and left for incubation 2.5h. • The products will evaluated under UV lamp on 1% agarose gel, where we expect two bands, one for plasmid (13.922bp) and the other insert (432bp) Methods left to be completed for this project – prospective • Agrobacterium tumefaciens transformation by freeze-thaw methods • Arabidopsis thaliana transformation by floral dip method • Expression pattern visualization Agrobacterium tumefaciens transformation by freeze-thaw methods • Freeze thaw-method (Holsters M. et al., 1987) , similar to heat shock method, using 20mM CaCl2 and dry ice or liquid nitrogen to freeze the cells. Floral dip • Transformed Agrobacterium strain GW301 is re-suspended to a freshly made infiltration media. Infiltration media contains : 10mM MgCl2, 5% sucrose, 0.44mM 6-benzyladenine (BA), 0.3% silwet L-77, 1x Gamborg s vitamin solution and autoclaved water. • Dip the plants into the solutions (infiltration media and agrobacterium with our plasmid) – each pot with our plant is kept minimum for 5 minutes • Plants are grown in growth chamber for minimum 3 weeks and wait for the seed germination • Seeds are collected and sterilized, placed on MS medium plates containing kanamycine (5000 seeds per MS plate) • Put the MS plates (with the seeds) to growth chamber and wait for 2 weeks. • Transgenic plants stay green ,they are bigger and develop true leaves compared to the nontransgenic seedlings, which turn to dark green and eventually die Arabidopsis thaliana transformation- Floral dip method Liu Z., et al., 2010. Examination of expression • Staining is done with X-Gluc (a substrate for GUS ) resulting in a dark-blue insoluble cleavage product. • Fix the tissue with a FAA fixative. • Visualize with a microscope attached to a digital camera or store the samples at 4C for later use. Liu Z., et al., 2010. Short discussion for the current work done by today • • In this project initially we planed to express U-OMP 16 in Arabidopsis thaliana leaves and to verify the expression levels by the beginning of 2014 ∕ 2015 academic year. Unfortunately I have not been able to complete all the planned activities, some of the reason may be as follows: The project idea came into existence in September 2013, the materials (bacterial cells, Arabidopsis thaliana seeds, agrobacterium tum. cells and the pBI101 plasmid) took more then 6 months to arrive to our university. My wish was to do the project fully in IUS laboratory facilities , even though I had to improvise in order to complete some of the methods. The setup of the laboratories took some time. Technical reasons made this project to prolong for almost more then 2 months. For example the received pBI101 plasmid cells were not viable after two months of storage in -20C. Needed to order again and it took around a month to arrive from USA. Initial primer set for PCR didn’t work , more the 10 PCR with different annealing temperature were done but the insert could not be amplified. This took me more then a month. Later on my mentor designed new reverse primer (without histidine 6x taq sequence) and the PCR worked from the first try. To receive the new primer I have waited around 3 weeks. Lastly , the Arabidopsis thaliana plants were grown almost 6 months in our growth chamber , 24 ∕ 7. Seeds were collected and stored at room temperature in paper towels. The plants planed for the transformation suddenly died out 2 weeks ago and new plant need to be grown for the transformation, in order to be transformed the plants have to grow 6 more weeks. Short conclusion • This work can serve as a an important step for the later study, that may include functional in vitro and in vivo assays. Therefore, the final project results expected are in vitro activity of U-OMP 16 protein in Arabidopsis thaliana, the stimulation of DC (Dentritic cells) cells and microphages as it is already proven in the Nicotiana benthamiana plant. • These studies will set the fundament in the development of a plant based vaccine, by expressing U-OMP16 protein in our plant. It is expected, if administrated orally, to boost immune response, and therefore represent an excellent treatment in the control of Brucellosis. Some of the References • Karina A. et al., 2010.The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern that activates Dendritic Cells In Vivo, Induces a Th1 Immune Response and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis.J Immunol , 184:5200-5212 • Guillermo H. et al., 2004. Lipoproteins, Not Lipopolysaccharide, Are the Key Mediators of the Proinflammatory Response Elicited by Heat-Killed Brucella abortus.J Immunol , 173:4635-4642; • Sylvestre Marillonnet wet al., 2004.In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. PNAS: 101 (18) 6852–6857.